Clere AG (CAG0) AI Stock Analysis
Clere AG
(Hamburg:CAG0)
No summary available
Clere AG (CAG0) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 82.04M
- Dividend Yield
- 2.16%
- Average Volume (3M)
- 337
- Price to Earnings (P/E)
- 14.6
- Beta (1Y)
- 0.19
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- Germany
- Employees
- ―
- Sector
- Consumer Goods
- Sector Strength
- 57
- Industry
- Independent Power Producers
Clere AG Business Overview & Revenue Model
Company Description
Clere AG is a Canadian investment company. It is engaged in investments and participation in the field of environment and power engineering. The company provides finance to medium-sized companies and invests in renewable energy production projects.
Clere AG Peers Comparison
Overall Rating
DE:COP53Neutral
DE:B8FK51Neutral
DE:BNN44Neutral
DE:AAQ140Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 57Neutral | $3.13B | 9.23 | -34.32% | 3.14% | -25.56% | -353.61% |
| 53Neutral | EUR 1.50B | 43.42 | 4.19% | 1.74% | ― | ― | |
| 51Neutral | EUR 17.81M | -1.45 | -127.78% | ― | ― | ― | |
| 44Neutral | EUR 61.61M | -4.27 | 590.52% | ― | ― | ― | |
| 40Underperform | EUR 21.34M | -7.44 | -32.36% | ― | 1.81% | 42.09% |
* Consumer Goods Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:CAG0 | Clere AG | 11.60 | -0.84 | -6.77% | |
| DE:AAQ1 | aap Implantate | 1.45 | -0.01 | -0.68% | |
| DE:B8FK | Biofrontera AG | 2.93 | 0.26 | 9.74% | |
| DE:BNN | B.R.A.I.N. Biotechnology Research and Information Network | 2.82 | 0.49 | 21.03% | |
| DE:CNW | co.don AG | 0.01 | -0.01 | -40.00% | |
| DE:COP | CompuGroup Medical | 28.45 | 4.30 | 17.83% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.